海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
15件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Available
- Proactive treatment with 0.03% tacrolimus cream in children with moderate/severe dermatitis
- Atopic Dermatitis MedDRA version: 17.1 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- China
- 2015-04-13
Not Available
- The CREAM Study - Children with Eczema Antibiotic Management Study
- Atopic Eczema MedDRA version: 14.1 Level: LLT Classification code 10003641 Term: Atopic eczema System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- United Kingdom
- 2012-07-27
Not Available
- Dermatitis Study
- stabilized atopic dermatitis MedDRA version: 20.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000018018 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- China
- 2017-09-21
Not Available
- An Open-label, Multicenter Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AEB1102 in Patients with Arginase I Deficiency
- Arginase 1 deficiency Hyperargininemia MedDRA version: 20.0 Level: PT Classification code 10062695 Term: Arginase deficiency System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Canada, Portugal, United Kingdom, United States
- 2018-10-30
Not Available
- Study to assess the safety and efficacy of CDZ173 in patients with APDS/PASLI
- APDS/PASLI (Activated phosphoinositide 3-kinase delta syndrome/ p110d-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency);Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Belarus, Czech Republic, Ireland, Netherlands, Russian Federation, United Kingdom, United States
- 2015-01-08